Read our latest news

Press releases

Jun18

- Activities to Resume Enrollment in IGNITE DMD Phase I/II Clinical Trial are Underway

- Conference Call Scheduled for Today at 8:30 A.M. ET

May19

- Data Reinforce Potential of SGT-001 as an Important Treatment Candidate for DMD -

- Company Continues to Advance Gene Therapy Portfolio -

May15

Solid Biosciences today announced that new preclinical data from its DMD programs will be presented at the 21st Annual Meeting of The American Society of Gene and Cell Therapy (ASGCT).

View our media

Gus

Gus (10) Peterborough, NH

Gals for Cal, women's triathlon 2016

Gals for Cal, women's triathlon 2016

Gals for Cal, women's triathlon 2016

Solid Mission

Solid Organization

Solid Community

Charity Collaboration

Contact information

Kate Niazi-Sai
Senior Director, Corporate Affairs 
media@solidbio.com

More information about Solid?

Please subscribe to receive our latest news